Statins: a tale of two pathways—cardiovascular savior, renal ineffectual

Statins are effective in improving outcomes in the general population. However, in patients with chronic kidney disease (CKD), clinical outcomes and therapeutic approaches require careful interpretation from multiple perspectives. Managing dyslipidemia in CKD presents unique challenges requiring a c...

Full description

Saved in:
Bibliographic Details
Main Author: Jihyun Yang
Format: Article
Language:English
Published: Sungkyunkwan University School of Medi 2025-03-01
Series:Precision and Future Medicine
Subjects:
Online Access:http://pfmjournal.org/upload/pdf/pfm-2025-00065.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849735896459378688
author Jihyun Yang
author_facet Jihyun Yang
author_sort Jihyun Yang
collection DOAJ
description Statins are effective in improving outcomes in the general population. However, in patients with chronic kidney disease (CKD), clinical outcomes and therapeutic approaches require careful interpretation from multiple perspectives. Managing dyslipidemia in CKD presents unique challenges requiring a comprehensive understanding of alterations in lipid metabolism in renal dysfunction. This review explored the key factors influencing statin efficacy, safety, and guideline recommendations in the CKD population, with a focus on lipid-lowering strategies tailored to renal function.
format Article
id doaj-art-8a958b6d2ff84f1e9e87ef6a5889e2da
institution DOAJ
issn 2508-7940
2508-7959
language English
publishDate 2025-03-01
publisher Sungkyunkwan University School of Medi
record_format Article
series Precision and Future Medicine
spelling doaj-art-8a958b6d2ff84f1e9e87ef6a5889e2da2025-08-20T03:07:25ZengSungkyunkwan University School of MediPrecision and Future Medicine2508-79402508-79592025-03-0191435210.23838/pfm.2025.00065184Statins: a tale of two pathways—cardiovascular savior, renal ineffectualJihyun Yang0 Division of Nephrology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, KoreaStatins are effective in improving outcomes in the general population. However, in patients with chronic kidney disease (CKD), clinical outcomes and therapeutic approaches require careful interpretation from multiple perspectives. Managing dyslipidemia in CKD presents unique challenges requiring a comprehensive understanding of alterations in lipid metabolism in renal dysfunction. This review explored the key factors influencing statin efficacy, safety, and guideline recommendations in the CKD population, with a focus on lipid-lowering strategies tailored to renal function.http://pfmjournal.org/upload/pdf/pfm-2025-00065.pdfhydroxymethylglutaryl-coa reductase inhibitorshydroxymethylglutaryl coa reductaseshyperlipidemiasrenal dialysisrenal insufficiency, chronic
spellingShingle Jihyun Yang
Statins: a tale of two pathways—cardiovascular savior, renal ineffectual
Precision and Future Medicine
hydroxymethylglutaryl-coa reductase inhibitors
hydroxymethylglutaryl coa reductases
hyperlipidemias
renal dialysis
renal insufficiency, chronic
title Statins: a tale of two pathways—cardiovascular savior, renal ineffectual
title_full Statins: a tale of two pathways—cardiovascular savior, renal ineffectual
title_fullStr Statins: a tale of two pathways—cardiovascular savior, renal ineffectual
title_full_unstemmed Statins: a tale of two pathways—cardiovascular savior, renal ineffectual
title_short Statins: a tale of two pathways—cardiovascular savior, renal ineffectual
title_sort statins a tale of two pathways cardiovascular savior renal ineffectual
topic hydroxymethylglutaryl-coa reductase inhibitors
hydroxymethylglutaryl coa reductases
hyperlipidemias
renal dialysis
renal insufficiency, chronic
url http://pfmjournal.org/upload/pdf/pfm-2025-00065.pdf
work_keys_str_mv AT jihyunyang statinsataleoftwopathwayscardiovascularsaviorrenalineffectual